Health

Results: 4321-4332 of 8801

PR Newswire associated0

NHS Supply Chain selects Leidos for cyber security

LifeArc Ventures 2024: new investments, targeted follow-ons and substantive portfolio progress

PR Newswire associated0

Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics

Business Wire logo

Amicus Therapeutics Launches Amicus Ignite, a Proactive Community Funding Programme for Initiatives That Support People Living With Pompe Disease

Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe

Comanche Biopharma Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway (ILAP) Steering Group for CBP-4888, an Investigational siRNA Drug Candidate for the Treatment of sFlt1-mediated Preterm Preeclampsia

EP2_4 Receptor (Photo: Business Wire)

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

(Photo: Ferrer)

Ferrer is Recognized for Its Best-in-class Ethics and Compliance Program

Business Wire logo

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Business Wire logo

Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Business Wire logo

Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines

PR Newswire associated0

EUROPEAN COMMISSION APPROVES BLINCYTO® IN PHILADELPHIA CHROMOSOME-NEGATIVE CD19-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONSOLIDATION PHASE